Interaction of total RPS3 with HNRNPU showed a decrease in the cytoplasmic fraction of NRAS mutant melanoma cells treated with MEKi and in BRAF mutant cells treated with combination mBRAFi/MEKi as assessed by PLA analysis. This evidence concerns the gene NRAS and melanoma.